Literature DB >> 14627805

Interleukin-6 represses the transcription of the CCAAT/enhancer binding protein-alpha gene in hepatoma cells by inhibiting its ability to autoactivate the proximal promoter region.

Pelagia Foka1, Scott A Irvine, Feray Kockar, Dipak P Ramji.   

Abstract

The cytokine interleukin-6 (IL-6) plays key roles in the immune and inflammatory responses, acute-phase reaction and hematopoiesis. Such biological actions of IL-6 are characterised by both the activation and the inhibition of gene transcription. Unfortunately, in contrast to gene activation, the mechanism by which IL-6 suppresses transcription remains largely unclear. We have, therefore, investigated this aspect using the Xenopus laevis CCAAT/enhancer binding protein-alpha (C/EBPalpha) gene promoter as a model. We show by transient transfection assays of various promoter-luciferase DNA constructs into hepatoma cells that a C/EBP recognition sequence in the proximal promoter region is essential for the IL-6-mediated repression. Electrophoretic mobility shift assays showed that C/EBPalpha was the major protein that bound to this site and, consistent with its expression pattern, the binding was reduced when the cells were exposed to IL-6. Co-transfection assays revealed for the first time that the ability of C/EBPalpha, but not C/EBPbeta or Sp1, to transactivate the promoter was decreased dramatically when the cells were incubated with IL-6. These studies, therefore, identify a novel mechanism for IL-6-mediated repression of gene transcription that involves a reduction in C/EBPalpha-mediated activation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14627805      PMCID: PMC290246          DOI: 10.1093/nar/gkg861

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  44 in total

1.  LPS and TNFalpha induce SOCS3 mRNA and inhibit IL-6-induced activation of STAT3 in macrophages.

Authors:  J G Bode; A Nimmesgern; J Schmitz; F Schaper; M Schmitt; W Frisch; D Häussinger; P C Heinrich; L Graeve
Journal:  FEBS Lett       Date:  1999-12-17       Impact factor: 4.124

2.  A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA.

Authors:  P Descombes; U Schibler
Journal:  Cell       Date:  1991-11-01       Impact factor: 41.582

Review 3.  The role of C/EBP isoforms in the control of inflammatory and native immunity functions.

Authors:  V Poli
Journal:  J Biol Chem       Date:  1998-11-06       Impact factor: 5.157

4.  IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses.

Authors:  Z Xing; J Gauldie; G Cox; H Baumann; M Jordana; X F Lei; M K Achong
Journal:  J Clin Invest       Date:  1998-01-15       Impact factor: 14.808

Review 5.  IL-6-regulated transcription factors.

Authors:  S Akira
Journal:  Int J Biochem Cell Biol       Date:  1997-12       Impact factor: 5.085

6.  Transcriptional inhibition by interleukin-6 of the class A macrophage scavenger receptor in macrophages derived from human peripheral monocytes and the THP-1 monocytic cell line.

Authors:  H S Liao; A Matsumoto; H Itakura; T Doi; M Honda; T Kodama; Y J Geng
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-08       Impact factor: 8.311

7.  The ovine CCAAT-enhancer binding protein delta gene: cloning, characterization, and species-specific autoregulation.

Authors:  G E Davies; G Sabatakos; A Cryer; D P Ramji
Journal:  Biochem Biophys Res Commun       Date:  2000-05-10       Impact factor: 3.575

Review 8.  Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway.

Authors:  P C Heinrich; I Behrmann; G Müller-Newen; F Schaper; L Graeve
Journal:  Biochem J       Date:  1998-09-01       Impact factor: 3.857

9.  Expression of the genes encoding CCAAT-enhancer binding protein isoforms in the mouse mammary gland during lactation and involution.

Authors:  G Sabatakos; G E Davies; M Grosse; A Cryer; D P Ramji
Journal:  Biochem J       Date:  1998-08-15       Impact factor: 3.857

10.  Renal CCAAT/enhancer-binding proteins in experimental diabetes mellitus.

Authors:  I Z Zador; C C Hsieh; J Papaconstantinou
Journal:  Nephron       Date:  1998       Impact factor: 2.847

View more
  6 in total

1.  Human monocytes accelerate proliferation and blunt differentiation of preadipocytes in association with suppression of C/EBPΑ mRNA.

Authors:  Jacob Couturier; Sanjeet G Patel; Dinakar Iyer; Ashok Balasubramanyam; Dorothy E Lewis
Journal:  Obesity (Silver Spring)       Date:  2011-08-25       Impact factor: 5.002

2.  Induction of multilineage markers in human myeloma cells and their down-regulation by interleukin 6.

Authors:  Shangqin Liu; Ken-ichiro Otsuyama; Zi Ma; Saeid Abroun; Karim Shamsasenjan; Jakia Amin; Hideki Asaoku; Michio M Kawano
Journal:  Int J Hematol       Date:  2007-01       Impact factor: 2.490

3.  The expression of a disintegrin and metalloproteinase with thrombospondin motifs 4 in human macrophages is inhibited by the anti-atherogenic cytokine transforming growth factor-β and requires Smads, p38 mitogen-activated protein kinase and c-Jun.

Authors:  Rebecca C Salter; Konstantinos Arnaoutakis; Daryn R Michael; Nishi N Singh; Tim G Ashlin; Melanie L Buckley; Alvin P L Kwan; Dipak P Ramji
Journal:  Int J Biochem Cell Biol       Date:  2011-02-18       Impact factor: 5.085

4.  A critical role for the Sp1-binding sites in the transforming growth factor-beta-mediated inhibition of lipoprotein lipase gene expression in macrophages.

Authors:  Scott A Irvine; Pelagia Foka; Sarah A Rogers; James R Mead; Dipak P Ramji
Journal:  Nucleic Acids Res       Date:  2005-03-08       Impact factor: 16.971

5.  Chronic inflammation contributes to the development of hepatocellular carcinoma by decreasing miR-122 levels.

Authors:  Changfei Li; Mengmeng Deng; Jun Hu; Xin Li; Lizhao Chen; Ying Ju; Junli Hao; Songdong Meng
Journal:  Oncotarget       Date:  2016-03-29

6.  Interleukin-6 induces impairment in human subcutaneous adipogenesis in obesity-associated insulin resistance.

Authors:  Shamma Almuraikhy; Wael Kafienah; Moataz Bashah; Ilhame Diboun; Morana Jaganjac; Fatima Al-Khelaifi; Houari Abdesselem; Nayef A Mazloum; Mohammed Alsayrafi; Vidya Mohamed-Ali; Mohamed A Elrayess
Journal:  Diabetologia       Date:  2016-06-24       Impact factor: 10.122

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.